Comparison and Analysis of Blood Loss Formulas

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03516552

Enrollment

100

Registered

2018-05-04

Start date

2018-01-01

Completion date

2018-08-10

Last updated

2019-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Loss

Brief summary

Although it has been pointed that estimates are significantly inexact and different from each other, the actual accuracy of them has not been properly investigated and compared.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 90 Years

Healthy volunteers

Inclusion criteria

\- Adults 18 - 90 yrs.

Exclusion criteria

* Suspected or confirmed coagulopathy (including current treatment with anticoagulants or antiplatelet agents). * Surgical blood loss volume \< 200 ml. * Requirement for surgical gauzes during surgery, including conversion to open surgical techniques. * Transfusion of red blood cells (RBCs) during the perioperative period. * Significant postoperative bleeding (\> 50 ml in surgical drains) or any other type of significant blood loss. * Fluid infusions or vasoactive drugs after the first 24 postoperative hours.

Design outcomes

Primary

Measure	Time frame
Differences on blood loss estimation.	72 hours.

Countries

Spain

Outcome results